Yahoo
NYSE - Nasdaq Real Time Price USD

AptarGroup, Inc. (ATR)

130.18 +3.01 (+2.37%)
As of 1:26:12 PM EDT. Market Open.
Trade ATR on Coinbase
ATR Q3 2026 earnings call
October 30, 2026 at 9 AM EDT
Chart Range Bar
Loading chart for ATR
  • Previous Close 127.17
  • Open 128.63
  • Bid 130.30 x 10000
  • Ask 130.49 x 10000
  • Day's Range 128.63 - 130.72
  • 52 Week Range 103.23 - 146.91
  • Volume 195,077
  • Avg. Volume 454,390
  • Market Cap (intraday) 8.277B
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) 23.58
  • EPS (TTM) 5.54
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield 1.92 (1.51%)
  • 1y Target Est 162.25
  • Morningstar Rating Rating available with Stock Picks access

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

www.aptar.com

14,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ATR
8.34%
S&P 500 (^GSPC)
12.61%

1-Year Return

ATR
6.29%
S&P 500 (^GSPC)
11.88%

3-Year Return

ATR
11.71%
S&P 500 (^GSPC)
87.23%

5-Year Return

ATR
15.17%
S&P 500 (^GSPC)
67.39%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 1.03B
Earnings 87.57M
Profit Margin 8.53%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
200M
400M
600M
800M
1B
8.0%
10.0%
12.0%

Analyst Insights

View More

Analyst Price Targets

135.00
162.25 Average
130.18 Current
220.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/9/2026
Analyst UBS
Rating Action Initiated
Rating Neutral
Price Action Announces
Price Target 135

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.22%

  • Return on Assets (ttm)

    6.14%

  • Return on Equity (ttm)

    13.46%

  • Revenue (ttm)

    3.93B

  • Net Income Avi to Common (ttm)

    362.52M

  • Diluted EPS (ttm)

    5.54

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    197.27M

  • Total Debt/Equity (mrq)

    52.78%

  • Levered Free Cash Flow (ttm)

    265.98M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: